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Introduction
Rab18 is one of the most highly conserved Rab GTPase regula-
tors of membrane traffic being present in the last eukaryotic 
common ancestor of both the plant and animal kingdoms (Elias 
et al., 2012; Klöpper et al., 2012). A defined biological function 
has remained elusive, partly because it was lost in the budding 
yeast lineage used for the genetic screens for regulators of mem-
brane traffic. Rab18 has been linked to lipid droplet formation 
(Martin et al., 2005; Ozeki et al., 2005), ER–Golgi trafficking 
(Dejgaard et al., 2008), and the regulation of secretory granules 
(Vazquez-Martinez et al., 2007) and peroxisomes (Gronemeyer 
et al., 2013), and may be exploited during hepatitis C infection 
(Salloum et al., 2013). However, no clear molecular function or 
site of action has been defined for Rab18, despite the fact that 
loss-of-function mutations are found in the autosomal-recessive 
human neurological and developmental disorder Warburg Micro 
syndrome (Bem et al., 2011). These children suffer from 
multiple specific developmental abnormalities in brain and eye 
development, profound global developmental delay, and neuro-
degeneration (Bem et al., 2011). However, the pattern of Rab18 
conservation in both plants and animals indicates that the es-
sential cellular function is unlikely to be specific to neuronal 
cells (Lütcke et al., 1994; Klöpper et al., 2012).
In addition to Rab18, a known Rab regulatory complex is 
mutated in Warburg Micro syndrome (Aligianis et al., 2005, 
2006; Handley and Aligianis, 2012; Handley et al., 2013). This 
is the Rab3 GTPase-activating protein (GAP) complex origi-
nally identified using biochemical purification from brain tissue 
as a cellular factor promoting GTP hydrolysis by Rab3 (Fukui 
et al., 1997; Nagano et al., 1998). Like Rab18, the Rab3GAP 
complex is both more widely conserved and more broadly ex-
pressed than Rab3 and is ubiquitously expressed in human tis-
sues (Nagano et al., 1998), raising the possibility that regulation 
of Rab3 is not its only function.
Simple logic suggests that the Rab3GAP complex and 
Rab18 act in the same pathway because mutations result in the 
same disease phenotype. We therefore set out to identify the 
cellular site of action of Rab18 and its functional relationship 
with Rab3GAP. Two simple alternatives present themselves, either 
The ancestral Rab GTPase Rab18 and both subunits of the Rab3GAP complex are mutated in the human neurological and developmental disorder Warburg 
Micro syndrome. Here, we demonstrate that the Rab3GAP 
complex is a specific Rab18 guanine nucleotide exchange 
factor (GEF). The Rab3GAP complex localizes to the endo­
plasmic reticulum (ER) and is necessary for ER targeting 
of Rab18. It is also sufficient to promote membrane re­
cruitment of Rab18. Disease­associated point mutations 
of conserved residues in either the Rab3GAP1 (T18P and 
E24V) or Rab3GAP2 (R426C) subunits result in loss of the 
Rab18 GEF and membrane­targeting activities. Support­
ing the view that Rab18 activity is important for ER struc­
ture, in the absence of either Rab3GAP subunit or Rab18 
function, ER tubular networks marked by reticulon 4 were 
disrupted, and ER sheets defined by CLIMP­63 spread out 
into the cell periphery. Micro syndrome is therefore a dis­
ease characterized by direct loss of Rab18 function or loss 
of Rab18 activation at the ER by its GEF Rab3GAP.
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2012; Handley et al., 2013). Thus, if Rab3GAP functions as a 
Rab GEF, both of its subunits could be required for full nucleo-
tide exchange activity. We therefore tested the in vitro nucleo-
tide exchange activity of a purified Rab3GAP complex in 
addition to that of the individual Rab3GAP1/2 subunits (Fig. 1 a, 
see inset showing Coomassie brilliant blue–stained gel). Screening 
against a panel of Rabs revealed a specific GDP release activity 
directed toward Rab18, whereas no activity was seen toward 
Rab3, the other Rab implicated in Micro syndrome (Fig. 1 a). 
Kinetic analysis showed that catalytic efficiency (kcat/Km) to-
ward Rab18 is 3.6 × 104 M1s1 (Fig. 1 b). By comparison, 
the catalytic efficiencies of Rabex5 and DENND1 GEFs for 
Rab5 and Rab35 are 2.5 × 104 M1s1 (Delprato et al., 2004; 
Delprato and Lambright, 2007; Wu et al., 2011). Both subunits 
were required for this Rab18 GEF activity, and neither subunit 
alone stimulated GDP release above the basal level seen with 
other nontarget Rabs (Fig. 1 c).
Rab GEFs form part of the minimal machinery needed for 
Rab targeting (Barr, 2013; Blümer et al., 2013). The ability of the 
Rab3GAP complex to promote Rab18 recruitment to a heterolo-
gous membrane in vivo was therefore tested (Gerondopoulos et al., 
2012). When Rab3GAP2 was ectopically targeted to mitochondria, 
Rab3GAP acts downstream of Rab18 as an effector complex for 
the active GTP form of Rab18, or Rab3GAP acts upstream of 
Rab18 as a potential guanine nucleotide exchange factor (GEF) 
regulator promoting Rab18 activation. The evidence presented 
here provides strong support for the hypothesis that the Rab3GAP 
complex is the cellular GEF activating Rab18, and this activity 
is required for Rab18 localization to the ER where it acts in a 
pathway maintaining normal ER morphology.
Results
Rab3GAP is a Rab18 GEF
Most disease-causing mutations in Rab3GAP1 are frameshift 
and nonsense mutations likely to affect protein expression 
(Handley and Aligianis, 2012; Handley et al., 2013). However, 
several missense loss-of-function mutations cluster in a highly 
conserved N-terminal domain of Rab3GAP1, suggesting this 
is an important function determinant of Rab3GAP activity dis-
crete from the C-terminal Rab3 GAP domain (Handley and 
Aligianis, 2012; Handley et al., 2013). Rab3GAP is a binary 
complex formed from two different subunits and mutations in 
either subunit cause Micro syndrome (Handley and Aligianis, 
Figure 1. Rab3GAP is a Rab18 GEF. (a) Rab3GAP complexes were used for GEF assays toward a representative group of Rab GTPases. Error bars indi-
cate the standard deviation of the mean (n = 3). Rab3GAP complexes and individual subunits (GAP1 and GAP2) were analyzed on protein gels stained 
with colloidal Coomassie brilliant blue stain. (b) Mant-GDP kinetic GEF assays were performed using the Rab3GAP complex and Rab18 as a substrate 
to derive catalytic efficiency (kcat/Km). Initial rates of nucleotide exchange were derived from three independent experiments and are plotted as a function 
of Rab3GAP concentration. (c) Rab3GAP complexes and individual subunits were used for GEF assays toward Rab1b, Rab2a, and Rab18. Error bars 
indicate the standard deviation of the mean (n = 3). (d) HeLa cells were cotransfected for 20 h with GFP-Rabs and Myc-tagged Rab3GAP1 in the presence 
and absence of the Tom70-FLAG-Rab3GAP2 mitochondrial-targeting fusion. The cells were fixed and then stained with FLAG and Myc antibodies; Rabs 
were visualized using GFP fluorescence. Bars are marked in the figure.
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its expression triggered recruitment of both coexpressed 
Rab3GAP1 and Rab18 to this compartment (Fig. 1 d). Omis-
sion of Rab3GAP2 resulted in loss of this Rab18 recruitment 
activity (Fig. 1 d). Rab3GAP therefore fulfils the requirements 
expected of a specific and highly active Rab18 GEF by promot-
ing membrane association of Rab18.
Effect of disease-associated mutations on 
Rab18 GEF activity
The effects of known disease-causing point mutations in 
Rab3GAP1 and Rab3GAP2 were then tested. First, recombi-
nant Rab3GAP complexes were made using Rab3GAP1 
T18P or E24V and wild-type Rab3GAP2, or wild-type 
Rab3GAP1 and Rab3GAP2 R426C (Fig. 2 a). Of these com-
plexes, only the form with both wild-type subunits showed 
activity toward Rab18 (Fig. 2 a). Complexes carrying either 
a mutant Rab3GAP1 or Rab3GAP2 subunit showed no activ-
ity toward Rab18 above the basal level seen with related non-
target Rabs (Fig. 2 a). Analysis of the GAP activity of the 
complex toward Rab3a and Rab3b showed that this is due to 
the Rab3GAP1 subunit of the complex and does not require 
the Rab3GAP2 subunit (Fig. 2 b). Furthermore, screening of 
Rab3GAP1 against a panel of human Rabs confirmed that it 
showed greatest activity toward Rab3a, Rab3b, and Rab3c, 
as expected (Fukui et al., 1997; Nagano et al., 1998), but also 
has some activity toward a subset of other Rabs, although not 
Rab18 (Fig. S1 a). However, disease-associated point mu-
tants in Rab3GAP1 had no effect on the GAP activity toward 
the Rab3 family, or the other potential targets Rab5a and 
Rab43 (Fig. 2 c; and Fig. S1 a, inset bar graph). No GAP ac-
tivity of either wild-type or mutant Rab3GAP1 toward Rab18 
was detected.
In agreement with the biochemical data defining a spe-
cific Rab18 GEF activity, the ability of the resulting mutant 
complexes to drive mitochondrial recruitment of Rab18 was 
abolished in the heterologous membrane-targeting assay 
(Fig. 2 d). These same mutations did not affect the capacity 
of Rab3GAP2 to recruit Rab3GAP1. The Rab3GAP complex 
is therefore a Rab18 GEF that forms part of the membrane-
targeting machinery for Rab18, and Rab3GAP mutations as-
sociated with Micro syndrome disrupt this activity. These 
same mutations do not alter the GAP activity of this com-
plex toward Rab3, making it unlikely that reduced GTP 
hydrolysis by Rab3 is the major change leading to Warburg 
Micro syndrome.
Figure 2. Disease-associated mutations in Rab3GAP1 and Rab3GAP2 
result in loss of Rab18 GEF activity. (a) A schematic of the Rab3GAP com-
plex showing the Rab3 GAP domain and the conserved N-terminal region 
of Rab3GAP1. Pathological missense mutations in Rab3GAP1 and Rab3GAP2 
are marked. Wild-type and disease mutant Rab3GAP complexes were used 
for GEF assays toward Rab1b, Rab2a, and Rab18. Error bars indicate 
the standard deviation of the mean (n = 3). (b) Wild-type Rab3GAP1, 
Rab3GAP1 and Rab3GAP2, or (c) wild-type and disease mutant Rab-
3GAP1 were used for GTPase assays with Rab3a or Rab3b. Error bars 
indicate the range (n = 2). This is a subset of the full screening data pre-
sented in the inset bar graph panel of Fig. S1 a. (d) HeLa cells were 
cotransfected for 20 h with GFP-Rabs, wild-type and disease mutant 
Myc-tagged Rab3GAP1, and the Tom70-FLAG-Rab3GAP2 mitochondrial- 
targeting fusion as indicated in the figure. The cells were fixed and then 
stained with FLAG and Myc antibodies; Rabs were visualized using GFP 
fluorescence. Bars are marked in the figure.
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Figure 3. Analysis of Rab18 and Rab3GAP localization to the ER. (a) Western blot of COS7 control cells and COS7 cells expressing GFP-Rab18 with 
antibodies to endogenous Rab18 and GFP. (b) GFP-Rab18, reticulon 4 (Rtn4), and CLIMP-63 staining is shown in COS7 cells. (c) Calnexin staining and 
mCherry (mCh)-tagged Rab18 are shown in HeLa cells. (d) COS7 cells expressing GFP-Rab18 were stained for Rab3GAP1 and markers for COP I (-COP), 
COP II (Sec31), ERGIC-53, and LAMP1. Arrowheads in the enlarged region show details of Rab3GAP1 localization to ER tubules marked by GFP-Rab18. 
(e) The enlarged region corresponding to the yellow boxed area in d shows details of the Rab3GAP1 and different compartment markers. Bars are marked 
in the figure.
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cytoplasmic pattern (Fig. 4 d). In addition to the loss of Rab18-
positive tubular networks, ER sheets with dynamic edges ex-
tended into the cell periphery (Fig. 4 d and Videos 2–5). These 
results support the idea that Rab18 membrane association and 
localization to the ER requires the activity of its cognate GEF 
in the form of the Rab3GAP complex. They also suggest that 
the Rab18 pathway is important for maintaining the structure of 
the ER.
Altered ER morphology in the absence of 
Rab18 or the Rab3GAP complex
The ER can be divided into a perinuclear region defined by the 
marker CLIMP-63, whereas the peripheral ER tubular network 
lacks CLIMP-63 but is positive for Rtn4 (Voeltz and Prinz, 
2007; Friedman and Voeltz, 2011). A role for Rab3GAP and 
Rab18 function in supporting this organization was tested in 
two different cell lines. When COS7 cells were depleted of 
Rab3GAP subunits or Rab18, CLIMP-63 spread away from the 
perinuclear region into the cell periphery, suggesting that ER 
sheets are expanded under these conditions (Fig. 5 a). This spread 
in CLIMP-63 was highly penetrant and observed in 80% of 
cells depleted of Rab3GAP subunits or Rab18 (Fig. 5 b, green 
bars). Measurements of the area occupied by CLIMP-63 indi-
cated that ER sheet volumes increased from 30% of the cell area 
to 60–80% in cells depleted of Rab3GAP subunits or Rab18 
(Fig. 5 b, blue bars). In addition to the redistribution of Rab18 
from the ER to the cytoplasm, HeLa cells depleted of Rab3GAP 
also showed a loss of calnexin staining in peripheral ER tubular 
networks (Fig. S1 c). Quantitation again confirmed that this 
was a highly penetrant effect, and fewer than 20% of Rab18- or 
Rab3GAP complex–depleted cells showed calnexin in periph-
eral ER tubular networks, compared with greater than 90% of 
control cells (Fig. S1, d and e). No alterations in the ER–Golgi 
Sec31 COP II vesicle coat protein or TGN46 trans-Golgi 
markers were observed in HeLa cells (Fig. S2 a). Similarly, the 
ERGIC-53 ER–Golgi recycling compartment marker and the 
TGN46 trans-Golgi marker were not obviously altered when 
Rab18 or the Rab3GAP complex was depleted in COS7 cells 
(Fig. S2 b). Western blots did not reveal major changes in the 
ER chaperones BIP, ERp72, or calnexin (Fig. S3 a), suggesting 
that the observed changes in ER morphology are not the result 
of a stress response and instead reflect a specific function for 
Rab18 at the ER.
To eliminate the possibility that indirect or off-target effects 
of the RNA interference procedure caused altered ER structure, 
rescue experiments were performed for Rab18. Cells were treated 
with two different Rab18 siRNA duplexes directed to the 3UTR 
of the mRNA, then transfected with empty vector or GFP-tagged 
Rab18. Depletion of Rab18 using the Rab18.8 3UTR duplex re-
sulted in the spread of CLIMP-63 into the peripheral region, and 
this was reversed by expression of GFP-Rab18 resistant to the 
siRNA (Fig. 6 a). Western blotting showed that the level of GFP-
Rab18 was similar to that of the endogenous Rab18, and that de-
pletion of Rab18 was efficient under these conditions (Fig. 6 b). 
Measurements of the area occupied by CLIMP-63 indicated that 
ER sheet volumes increased from 30% of the cell area to 60–80% 
in cells depleted of Rab18 with either of the Rab18 3UTR 
Localization of Rab18 and Rab3GAP to  
the ER
Because of differing reports that Rab18 is present on lipid drop-
lets, Golgi, and other organelles of the secretory pathway, the 
localization of Rab18 was investigated. Because antibodies ca-
pable of specifically detecting Rab18 on Western blots (Fig. S1 b) 
failed to detect any specific signal in immunofluorescence using 
a variety of different fixation protocols, cells expressing GFP-
Rab18 were used. Western blotting showed that GFP-Rab18 
was expressed at a similar level to the endogenous protein in 
COS7 cells (Fig. 3 a). These cells were then stained with the ER 
tubule and sheet markers reticulon 4 (Rtn4) and CLIMP-63, re-
spectively. At this level of expression, Rab18 was present on ER 
tubules marked by Rtn4 (Fig. 3 b), a region lacking the ER sheet 
marker CLIMP-63. In HeLa cells, mCherry-tagged Rab18 was 
found to be present in both the perinuclear region and the cell pe-
riphery and to overlap with the ER marker calnexin (Fig. 3 c).
The localization of the Rab3GAP complex was then 
investigated using an antibody to the Rab3GAP1 subunit. 
Rab3GAP1 was detected in punctate structures spread throughout 
the volume of the cell (Fig. 3 d). Many of these punctate struc-
tures overlapped with Rab18-positive ER tubules in the cell 
periphery (Fig. 3 d, marked by arrows in the enlarged region). 
However, they did not show any overlap with markers for either 
COP I or COP II vesicles, the ER–Golgi recycling compartment 
marker ERGIC-53, or the endosome and lysosome markers EEA1 
and LAMP1 (Fig. 3 d, and the enlarged region in Fig. 3 e). These 
observations are consistent with the idea that the Rab3GAP 
complex could activate Rab18 at the ER. However, the pattern 
of localization suggests that the Rab3GAP complex is restricted 
to a subdomain of the ER.
Rab3GAP complex regulates ER localization 
of Rab18
The requirement for Rab3GAP in Rab18 localization to the ER 
was then tested. Western blotting confirmed that Rab3GAP sub-
units, Rab18, and the negative control Rab7 were all efficiently 
depleted (Fig. S1 b). Furthermore, depletion of either subunit by 
siRNA affects levels of the other (Fig. S1 b), consistent with a 
report that deletion of Rab3GAP1 in mice results in loss of 
Rab3GAP2 protein (Sakane et al., 2006). Depletion of either 
subunit of the Rab3GAP complex resulted in loss of Rab18 
from ER tubules and accumulation in a diffuse pattern most 
probably reflecting cytoplasmic localization in over 80% of 
cells (Fig. 4, a and b). Biochemical fractionation showed that in 
control cells Rab18 was found only in the membrane fraction, 
and in the absence of the Rab3GAP complex it was partially re-
distributed to the cytosol fraction (Fig. 4 c).
The role of Rab18 activation in the dynamics of the ER 
was then followed using live-cell imaging of mCherry-tagged 
Rab18 and a GFP-tagged ER marker. Dynamic tubular networks 
undergoing rapid branch migration and the formation of new 
connections by tubule fusion characterized the ER in control 
cells (Fig. 4 d and Video 1), as expected. These features were lost 
in the absence of the Rab18 GEF. Depletion of either Rab3GAP1 
or Rab3GAP2 alone or in combination resulted in the loss of 
Rab18 from defined ER tubules and redistribution to a diffuse 
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duplexes tested (Fig. 6 c, green bars). In both cases this effect was 
rescued by expression of GFP-Rab18 (Fig. 6 c, blue bars). Live-
cell imaging of cells depleted of endogenous Rab18 using the 
Rab18.7 3UTR duplex resulted in the loss of dynamic ER tubu-
lar networks and the expansion of less dynamic sheet areas, and 
this was reversed by expression of mCherry-Rab18 resistant to 
the siRNA (Fig. 6 d and Videos 6–8).
Rab10 has previously been implicated in the regulation 
of ER structure (English and Voeltz, 2013), and its relationship 
to Rab18 was therefore investigated. Rab10 was depleted effi-
ciently (Fig. S3 a), but this resulted in only a partial spread of 
ER sheets to the cell periphery (Fig. 5, a and b). The localization 
of Rab10 and Rab18 was then compared in HeLa and COS7 
cells. Whereas Rab18 targeted to ER tubular networks in both 
Figure 4. Rab3GAP is required for ER lo-
calization of Rab18. (a) HeLa cells express-
ing GFP-Rab18 were depleted of Rab3GAP 
subunits (siGAP1 and siGAP2) for 72 h and 
then stained with a Rab3GAP1 antibody. The 
enlarged region from the yellow boxed area 
shows details of Rab18 localization. (b) The 
presence of GFP-Rab18 on ER tubules was 
scored for all conditions and plotted in the 
bar graph. Error bars indicate the standard 
deviation of the mean (n = 3 independent 
experiments). (c) HeLa cells were depleted 
of Rab3GAP subunits (GAP1 and GAP2) for 
72 h. Western blots show the distribution of 
endogenous Rab18 to the membrane pellet 
(P) and soluble (S) cytosol fractions marked 
by the Golgi membrane protein GM130 and 
tubulin, respectively. Rab3GAP1 depletion 
was confirmed by Western blotting. (d) COS7 
cells expressing a GFP-tagged ER marker and 
mCherry-tagged Rab18 were depleted of 
Rab3GAP subunits alone or in combination or 
Rab18 for 72 h then imaged at 1.5-s intervals 
using a spinning-disk confocal microscope. 
The entire cell is shown for t = 0, and a time 
series from the yellow boxed area is depicted 
in the enlarged regions. Bars are marked in 
the figure.
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cell lines, Rab10 only showed pronounced ER tubule localiza-
tion in COS7 cells (Fig. S3, b and c). Intriguingly, although de-
pletion of Rab10 did not cause a loss of Rab18 from the ER 
membrane, it did result in a shift to a partly sheet-like distri-
bution more like that of CLIMP-63 (Fig. S3 d). Although these 
results support the view that both Rab18 and Rab10 can be 
detected on the ER, they suggest that these two Rabs have dif-
ferent functions.
Warburg Micro syndrome and ER shaping
To confirm that the ER defects observed in cell lines depleted 
of Rab18 and Rab3GAP complex subunits are relevant for the 
human disease, the localization of CLIMP-63 and Rtn4 was 
investigated in two patient cell lines. These cell lines carried 
either the Rab18 L24Q nucleotide-binding site mutation, or 
the Rab3GAP1 (c.649-2A>G) splicing mutation (Aligianis et al., 
2005; Bem et al., 2011). In comparison to control fibroblasts, 
CLIMP-63 spread away from the perinuclear region into the cell 
periphery and clearly defined Rtn4-positive tubules were lost in 
both the Rab18 L24Q and Rab3GAP1 (c.649-2A>G) patient cell 
lines (Fig. 7 a). Measurements of the area occupied by CLIMP-
63 indicated that ER sheet volumes increased from 20% of the 
cell area to 60–70% in cells with mutant Rab18 or Rab3GAP1 
(Fig. 7 b). Spread of ER sheets and a loss of fragmentation of ER 
tubules were therefore observed in patient fibroblasts.
After the initial discovery of Rab3GAP and Rab18 muta-
tions it was found that the ER transmembrane protein TBC1D20 
is mutated in Warburg Micro syndrome and the blind sterile 
mouse (Liegel et al., 2013). TBC1D20 is a GAP for Rab1 and 
Rab2 with some limited activity toward Rab18 in vitro (Haas 
et al., 2007). TBC1D20 interacts with the reticulon family of 
ER-shaping proteins (Haas et al., 2007), and has been impli-
cated in secretion (Wendler et al., 2010). The relationship 
between Rab3GAP complex and TBC1D20 in ER shaping 
was therefore investigated. As already shown, depletion of the 
Rab3GAP1 and Rab3GAP2 subunits resulted in the redistribu-
tion of Rab18 to the cytoplasm, the spread of the ER sheet marker 
CLIMP-63, and fragmentation of the peripheral ER tubular 
network defined by Rtn4 (Fig. 7 c). By contrast, depletion of 
TBC1D20 resulted in a slight spread of the ER sheets marked 
by CLIMP-63 (Fig. 7 c). In addition, alterations in the distri-
bution of Rab18 to the peripheral ER reticular network were 
observed. Instead of precisely following the Rtn4-positive ER 
tubules as in the control samples, Rab18 spread across the fen-
estrations in the reticular network (Fig. 7 c). This created a hy-
brid webbed network in which fingers of Rtn4 are linked by 
sheets containing Rab18. Therefore, although loss of TBC1D20 
function results in altered ER structure, the differences in the 
phenotype suggest it plays a different role to the Rab3GAP 
complex and Rab18.
Figure 5. ER sheets spread into the cell periphery when Rab18 or its GEF 
complex is depleted. (a) COS7 cells were depleted of Rab3GAP subunits 
(GAP1 and GAP2), Rab18, or Rab10 for 72 h. Two different siRNA du-
plexes to Rab3GAP1 (GAP1.1 and GAP1.2) were used. The cells were 
fixed and then stained with antibodies to CLIMP-63 and reticulon 4 (Rtn4). 
DNA was stained with DAPI (blue in the merged panel). Dotted yellow lines 
mark the cell boundaries. The bar is marked in the figure. (b) The area 
of CLIMP-63 as a function of total cell area was measured using ImageJ 
(National Institutes of Health) for 50–70 cells per experiment, for three 
independent experiments (blue bars). Additionally, the percentage of cells 
showing spread CLIMP-63 was also counted (green bars). In both cases 
the mean values are plotted in the bar graph, with error bars indicating the 
standard deviation of the mean.
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Figure 6. Loss of dynamic ER tubules in Rab18-depleted cells. (a) COS7 cells were treated with control or Rab18.8 3-UTR siRNA for 52 h, then trans-
fected with empty vector or GFP-Rab18 for 20 h. Cells were fixed and then stained with antibodies to CLIMP-63 and Rtn4. Dotted yellow lines mark the cell 
boundaries. (b) COS7 cells were treated with control, Rab3GAP (siGAP1+2), Rab18.7, or Rab18.8 3-UTR siRNA for 52 h, then transfected with empty 
vector or GFP-Rab18 for 20 h. Cell lysates were Western blotted with antibodies to Rab18, GFP, Rab3GAP subunits, and tubulin as a loading control. 
Rab18 antibodies see multiple nonspecific bands; lines in the figure indicate endogenous Rab18 and GFP-Rab18. (c) The area of CLIMP-63 as a function 
of total cell area was measured using ImageJ for 40–60 cells per experiment, for three independent experiments. This was performed for cells expressing 
(blue bars) or not expressing (green bars) GFP-Rab18. Mean values are plotted in the bar graph, with error bars indicating the standard deviation of the 
mean. (d) COS7 cells expressing a GFP-ER marker were treated with control or Rab18.7 3-UTR siRNA for 52 h, then transfected with empty vector or 
mCherry-Rab18 for 20 h. The cells were then imaged at 2-s intervals using a spinning-disk confocal microscope. The entire cell is shown for t = 0, and a 
time series showing images every 4 s from the yellow boxed area is depicted in the enlarged regions. Bars are marked in the figure.
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Figure 7. Warburg Micro syndrome patient cell lines show altered ER morphology. (a) Control and patient fibroblasts were fixed and then stained with 
antibodies to CLIMP-63 and reticulon 4 (Rtn4). DNA was stained with DAPI (blue in the merged panel). (b) The area of CLIMP-63 as a function of total cell 
area was measured using ImageJ for 50–70 cells per experiment, for three independent experiments. The mean values are plotted in the bar graph, with 
error bars indicating the standard deviation of the mean. (c) COS7 cells expressing GFP-Rab18 were treated with control, Rab3GAP (siGAP1+GAP2), or 
TBC1D20 siRNA duplexes for 72 h. The cells were fixed and then stained with antibodies to CLIMP-63 and Rtn4. DNA was stained with DAPI (blue in the 
merged panel). The merged panel shows a comparison of GFP-Rab18 and Rtn4 localization to ER tubular networks. Bars are marked in the figure.
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and Prinz, 2007; Friedman and Voeltz, 2011). These domains 
are further specialized into functional regions, including the so-
called ER exit sites where biosynthetic cargo transport occurs, 
sites where lipid droplets form, and contact sites with other 
cellular organelles such as mitochondria, endosomes, and the 
plasma membrane (Friedman and Voeltz, 2011; Rowland and 
Voeltz, 2012). However, in most cases an essential requirement 
for normal ER morphology in these processes remains unclear. 
A series of factors required for ER tubular network formation 
have been identified, and these can be divided into factors pro-
moting ER tubule formation such as the reticulon, DP1 and 
REEP integral membrane protein family (Voeltz et al., 2006; 
Shibata et al., 2008; Park et al., 2010), and transmembrane 
GTPases of the atlastin family promoting ER tubule fusion to gen-
erate networks (Hu et al., 2009; Orso et al., 2009). Less is known 
about the mechanism of sheet formation, but the transmembrane 
protein CLIMP-63 is thought to localize to and stabilize ER 
sheets by acting as a luminal spacer (Klopfenstein et al., 2001; 
Shibata et al., 2010).
Rab GTPases can now be added to this emerging picture. 
In contrast to the factors already discussed, which are integral 
membrane proteins, Rabs are peripheral membrane proteins re-
cruited from the cytosol thought to act as regulators of mem-
brane fusion and organelle identity (Barr, 2013; Pfeffer, 2013). 
Rab10 is associated with ER networks and promotes ER tubule 
dynamics (English and Voeltz, 2013). In polarized cells, Rab10 
and its cognate GEF DENND4/CRAG are required together 
with a transmembrane sorting receptor TANGO1 for the baso-
lateral transport of collagen (Yoshimura et al., 2010; Lerner 
et al., 2013). This raises the intriguing possibility that polarized 
transport is already specified at the level of the ER. However, 
how Rab10 is activated at the ER and what its downstream ef-
fector proteins are remains unclear.
In this work we show that the Rab3GAP complex acti-
vates Rab18, and this is required for Rab18 recruitment to the 
ER. Further studies will be needed to define the downstream ef-
fector pathways coupling to Rab18, and it would be premature 
to specify what precise events Rab18 regulates. It may directly 
act in the pathway of lipid droplet biogenesis; however, details 
of effectors are crucial. The altered ER structure reported here 
suggests that Rab18 effectors may regulate ER tubule tethering 
and fusion, or perhaps act as inhibitors of ER sheet extension. 
Understanding the interplay between Rab18, Rab10, and tubu-
lar network–promoting factors of the reticulon and atlastin fam-
ilies will therefore be an important goal for future work.
Previous studies have implicated Rab18 in lipid droplet 
formation, and have reported that Rab18 is highly enriched on 
lipid droplets (Martin et al., 2005; Ozeki et al., 2005). However, 
these studies relied on high-level expression of Rab18 to induce 
alterations in lipid droplet apposition to ER membranes and 
Rab18 localization to lipid droplets (Martin et al., 2005; Ozeki 
et al., 2005). Under the conditions used here, where tagged 
Rab18 was expressed at levels similar to the endogenous pro-
tein, Rab18 was found on tubular networks forming the ER and 
was not enriched on lipid droplets. Lipid storage was increased 
twofold after 18 h in cells depleted of Rab18 or its GEF, suggest-
ing there is a link between Rab18 function and lipid droplets. 
Intriguingly, both TBC1D20 and Rab18 have been linked 
to ER-associated lipid droplet structures (Martin et al., 2005; 
Ozeki et al., 2005; Liegel et al., 2013; Salloum et al., 2013). To 
test if Rab3GAP, Rab18, and TBC1D20 play a general role in 
lipid droplet formation and turnover, cells were fed oleate–BSA 
complexes for 18 h to induce lipid droplet formation. These 
cells were then stained for ER markers CLIMP-63 and Rtn4, 
and lipid droplets were detected with BODIPY (Fig. S4 a). 
Western blotting confirmed efficient depletion of target proteins 
(Fig. S4 b). Compared with the control cells, BODIPY stained 
larger more intense structures clustered against the nucleus after 
depletion of Rab18 pathway components or TBC1D20 (Fig. S4 a), 
suggesting more lipid was stored. A time-course analysis of 
lipid storage and turnover revealed that after 18 h, cells depleted 
of Rab3GAP complex subunits, Rab18, or TBC1D20 showed 
twofold higher staining with BODIPY than control cells 
(Fig. S4 c). In all cases, after removal of oleate by transfer to 
fresh growth medium this signal declined at the same rate over 
the following 36 h (Fig. S4 d). Rab18, Rab3GAP, and TBC1D20 
are therefore not essential for lipid droplet formation or turn-
over under these conditions. Furthermore, neither mCherry-
tagged Rab18 nor the ER tubular network marker Rtn4 showed 
any obvious enrichment on lipid droplet structures (Fig. S5 a). 
Live-cell imaging showed that lipid droplets often lie adjacent 
to the ER tubular networks in control cells (Fig. S5 b) and move 
together with Rab18-positive ER tubular networks (Video 9). 
However, in cells depleted of Rab18 or the Rab3GAP complex, 
lipid droplets showed an increased rather than decreased asso-
ciation with ER sheets (Fig. S5 b). This change could poten-
tially facilitate lipid storage without requiring a direct role for 
Rab18 or the Rab3GAP complex in lipid droplet biogenesis.
Discussion
Rab3GAP is a Rab18 GEF
Rab3GAP1 and Rab3GAP2 were originally isolated from bovine 
brain as subunits of a complex promoting GTP hydrolysis by 
Rab3 (Fukui et al., 1997; Nagano et al., 1998). This has led to 
the suggestion that a defect in neurotransmission resulting from 
altered Rab3 function contributes to Warburg Micro syndrome 
(Aligianis et al., 2005, 2006). As we show here, the Rab3GAP 
complex also has specific and potent Rab18 GEF activity. 
Supporting the view that Rab18 is the physiological target of 
Rab3GAP, the catalytic efficiency of 3.6 × 104 M1s1 is equiva-
lent to Rab GEFs with known targets (Langemeyer et al., 2014). 
In agreement with this idea, disease-associated mutations in 
Rab3GAP abolish this Rab18 GEF activity and cause a loss of 
Rab18 from the ER in fibroblast cell lines. The presence of Rab18 
(Elias et al., 2012; Klöpper et al., 2012) and the Rab3GAP com-
plex in a wide variety of eukaryotes lacking Rab3, including 
plants, also supports the view that the essential cellular function 
of this pathway is not the regulation of neurotransmission. 
Neurological dysfunction may therefore be caused by more fun-
damental cellular defects linked to perturbed ER function.
ER regulation by Rab GTPase pathways
The ER is organized into two morphologically discrete domains, 
the perinuclear ER sheets and peripheral tubular networks (Voeltz 
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However, there was also increased association of ER sheets 
with lipid droplets in Rab18- or Rab18 GEF–depleted cells. 
One possibility is that this could facilitate lipid storage without 
requiring a direct role for Rab18 or its GEF complex.
Relationship of ER-shaping factors and 
human disease
A sobering feature of the proteins associated with ER network 
formation is their mutation in a spectrum of human neurological 
disorders (Blackstone, 2012). Atlastins, spastin, reticulon 2, 
REEP1, and REEP2 are all mutated in hereditary spastic para-
plegia (Hazan et al., 1999; Park et al., 2010; Montenegro et al., 
2012; Fink, 2013; Esteves et al., 2014), whereas Rab18 and the 
Rab3GAP1 and Rab3GAP2 subunits are mutated in Warburg 
Micro syndrome (Aligianis et al., 2005, 2006; Bem et al., 2011; 
Handley and Aligianis, 2012; Handley et al., 2013). In each 
case, these diseases are associated with progressive ascending 
spasticity. Other evidence supports the idea that Warburg Micro 
syndrome and hereditary spastic paraplegias (HSPs) should 
be considered as related disorders. A combination of mouse and 
human genetics has shown that the ER transmembrane protein 
TBC1D20 is mutated in Warburg Micro syndrome and the blind 
sterile mouse (Liegel et al., 2013). This is notable because 
TBC1D20 is a GAP for Rab1 and Rab2, and interacts with the 
reticulon family of proteins in the ER (Haas et al., 2007). 
TBC1D20 therefore provides a link between Warburg Micro 
syndrome and the reticulon family of ER-shaping proteins mu-
tated in some hereditary spastic paraplegias. Other evidence 
linking HSPs and Warburg Micro syndrome is provided by the 
identification of Rab3GAP2 mutations in corticospinal motor 
neuron disease (Novarino et al., 2014), an autosomal-recessive 
HSP. This correlation between altered ER structure and neuro-
logical disorders is intriguing, and provides further support for 
the view that ER form and function are closely linked. As al-
ready mentioned, diverse cellular processes are associated with 
the ER, and explaining the dependencies on structural organiza-
tion will be a complex task requiring the generation of specific 
experimental models to look at ER structure–function relation-
ships in neuronal cells and during development.
Materials and methods
Reagents and antibodies
General laboratory chemicals were obtained from Sigma-Aldrich and 
Thermo Fisher Scientific. Duplexes for Rab18, Rab3GAP1, and Rab3GAP2 
siRNA were obtained from Thermo Fisher Scientific and the sequences are 
listed in Table S1. A luciferase duplex was used as a control in all siRNA 
experiments. Commercially available antibodies were used to -tubulin 
(mouse DM1A; Sigma-Aldrich), Myc-epitope (mouse clone 9E10; Sigma-
Aldrich), FLAG-epitope (mouse monoclonal M2; Sigma-Aldrich), Rab7 
(rabbit clone D95F2; Cell Signaling Technology), Rab10 (rabbit D36C4; 
Cell Signaling Technology), Rab18 (mouse 60057 and rabbit polyclonal; 
ProteinTech), Rab3GAP1 (rabbit 21663; ProteinTech), Rab3GAP2 (rabbit 
NBP1-84199; Novus Biologicals), GM130 (mouse clone 35; BD), -COP 
(mouse G6160; Sigma-Aldrich), Sec31 (mouse clone 32; BD), TGN46 
(sheep; AbD Serotec), LMAN1/ERGIC-53 (mouse 1A8; Novus Biologi-
cals), calnexin (rabbit 10427; ProteinTech), ERp72 (rabbit clone D70D12; 
Cell Signaling Technology), PDI (rabbit clone C81H6; Cell Signaling Tech-
nology), GRP78/BiP (rabbit ab21685; Abcam), EEA1 (mouse clone 14; 
BD), LAMP1 (mouse clone H4A3; BD), NOGOA/Rtn4 (rabbit; AbD Sero-
tec), and CLIMP-63 (mouse; Enzo Life Sciences). Affinity-purified sheep 
anti-GFP polyclonal was made previously by us. Secondary antibodies 
raised in donkey to mouse, rabbit, sheep/goat, and human conjugated to 
HRP, Alexa 488, -555, -568, and -647 were obtained from Molecular 
Probes and Jackson ImmunoResearch Laboratories, Inc.
Molecular biology and Rab protein expression
Human Rab GTPases were amplified using PCR from human testis, fetus, 
and liver cDNA and cloned into pFAT2 for bacterial expression or pGFP-C2 
for eukaryotic expression of GFP-tagged Rabs (Fuchs et al., 2007; 
Yoshimura et al., 2010). Human Rab3GAP1 and Rab3GAP2 were ampli-
fied by PCR from human testis cDNA. Point mutations were introduced 
using the QuikChange method. Mammalian expression constructs were 
made using pcDNA4/TO and pcDNA5/FRT/TO vectors (Invitrogen). 
Mitochondrial targeted Rab3GAP was created in pcDNA5 by fusing the 
mitochondrial outer membrane targeting sequence of yeast Tom70p and 
three copies of the FLAG epitope sequence to the 5-prime end of the 
Rab3GAP1 or Rab3GAP2 cDNA. Rab proteins in pFAT2 were expressed in 
BL21 (DE3) pRIL at 18°C for 12–14 h. Cell pellets were disrupted in 20 ml 
IMAC20 (20 mM Tris-HCl, pH 8.0, 300 mM NaCl, 20 mM imidazole, and 
protease inhibitor cocktail; Roche) using an Emulsiflex C-5 system (Avestin, 
Inc.). Lysates were clarified by centrifugation at 16,000 rpm in a rotor 
(model JA-17; Beckman Coulter) for 30 min. To purify the tagged protein, 
0.5 ml of nickel-charged NTA-agarose (QIAGEN) was added to the clari-
fied lysate and rotated for 2 h. The agarose was washed three times with 
IMAC20 and the bound proteins eluted in IMAC200 (IMAC20 with 200 mM 
imidazole) collecting 1.5-ml fractions. All manipulations were performed 
on ice or in an 8°C cold room. Purified proteins were dialyzed against TBS 
(50 mM Tris-HCl, pH 7.4, and 150 mM NaCl) and then snap-frozen in liq-
uid nitrogen for storage at 80°C. Protein concentration was measured 
using the Bradford assay.
Cell culture
Patient cell lines, HeLa, HEK293, and COS7 cells were cultured in DMEM 
containing 10% bovine calf serum (Invitrogen) at 37°C and 5% CO2. For 
plasmid and siRNA transfection Mirus LT1 (Mirus Bio LLC) and Oligo-
fectamine (Invitrogen), respectively, were used according to the manufac-
turer’s instructions. For RNA interference experiments HeLa cells were 
plated at 18,000 cells per well and COS7 cells at 8,000 cells per well of 
a 6-well plate, respectively.
Purification of GEF complexes
FLAG- and Myc-tagged forms of Rab3GAP1 and Rab3GAP2 were tran-
siently expressed in 8 × 15-cm dishes of 70% confluent HEK293T cells. For 
this purpose 800 µl OptiMEM (Invitrogen) was mixed with 24 µl Mirus LT1, 
and after 5 min 6 µg of each plasmid DNA was added. After 25 min this 
transfection mix was added to the cells. After 40 h of growth the cell pellet 
was lysed for 20 min on ice in 5 ml cell lysis buffer (50 mM Tris-HCl, 
pH7.4, 1 mM EDTA, 150 mM NaCl, 0.5% [vol/vol] Triton-X 100, and 
protease inhibitor cocktail). Cell extracts were split into 1-ml aliquots and 
clarified by centrifugation at 20,000 g in a microfuge (model 5417R; 
Eppendorf) for 20 min. The FLAG-tagged proteins were isolated from the 
clarified cell lysate using 100 µl anti-FLAG M2 affinity gel (Sigma-Aldrich) 
for 4 h at 4°C. The beads were washed ten times with 1 ml of cell lysis buf-
fer, high salt buffer (50 mM Tris-HCl, pH 7.4, and 500 mM NaCl), and 
TBS, and then the proteins were eluted with 100 µl (200 µg/ml) FLAG-peptide 
in TBS containing 2 mM dithiothreitol. Eluted proteins were analyzed on 
7.5–10% SDS-PAGE gels stained with Coomassie brilliant blue, and con-
centrations estimated by comparison to a series of bovine serum albumin 
standards in the range of 0.1 mg to 1 mg. The peak fractions were snap-
frozen in liquid nitrogen for storage at 80°C without dialysis.
Nucleotide binding and Rab GEF screening
GEF assays were performed as described previously (Yoshimura et al., 
2010). Nucleotide loading was performed as follows: 10 µg GST-tagged 
Rab was incubated in 50 mM Hepes-NaOH, pH 6.8, 0.1 mg/ml BSA, 
125 µM EDTA, 10 µM Mg-GDP, and 5 µCi [3H]-GDP (10 mCi/ml; 5,000 Ci/
mmol) in a total volume of 200 µl for 20 min at 4°C. For standard GDP- 
releasing GEF assays, 100 µl of the loading reaction was mixed with 
10 µl (10 mM) Mg-GTP, 10–100 nM GEF, or a buffer control, and adjusted 
with assay buffer to a final volume of 120 µl. The GEF reaction occurred 
for 20 min at 30°C. After this, 2.5 µl were taken for a specific activity mea-
surement, and the remainder was split into two tubes, then incubated with 
500 µl ice-cold assay buffer containing 1 mM MgCl2 and 20 µl packed 
glutathione–Sepharose for 60 min at 4°C. After three washes with 500 µl 
ice-cold assay buffer the Sepharose was transferred to a vial containing 
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BX61; Olympus) with filtersets for DAPI, GFP/Alexa 488, -555, -568, and 
-647 (Chroma Technology Corp.), a camera (CoolSNAP HQ2; Roper Sci-
entific), and MetaMorph 7.5 imaging software (Molecular Dynamics Inc.). 
Illumination was provided by a Lumen 200-Watt metal halide light source 
(Prior Scientific, Inc.). Image stacks of 12–35 planes with a spacing 
of 0.2–0.4 µm through the cell volume were taken. Image stacks were 
maximum intensity projected and then merged to create 24-bit RGB TIFF 
files in MetaMorph. Images in 24-bit RGB format were then cropped in 
Photoshop CS3 and placed into Illustrator CS3 (Adobe Systems Inc.) to 
produce the figures.
For live-cell imaging using spinning-disk confocal microscopy, cells 
were plated in 35-mm dishes with a 14-mm no. 1.5 coverglass window in 
the bottom (MatTek Corporation). For imaging, the dishes were placed in 
a 37°C and 5% CO2 environment chamber (Tokai Hit) on the microscope 
stage. Imaging was performed at 37°C in 5% CO2 using an inverted 
microscope (model IX81; Olympus) with a 60×/1.42 NA oil immersion 
objective coupled to an Ultraview Vox spinning-disk confocal system (Perkin-
Elmer) fitted with an EM-CCD camera (model C9100-13; Hamamatsu Pho-
tonics). Exposure times were 50 ms using 6% laser power. Image stacks of 
six planes spaced 0.2 µm apart were taken at the time intervals shown in 
the figure for up to 1 h. A bright-field reference image was also taken to vi-
sualize cell shape. Maximum intensity projection of the fluorescent chan-
nels was performed in Volocity (PerkinElmer) to create 24-bit RGB TIFF files. 
Images in 24-bit RGB TIFF format were then placed into Adobe Illustrator 
CS3 to produce the figures.
Lipid storage assays
Oleate–BSA complexes were formed by incubating 2.1 mM fatty acid–free 
bovine serum albumin with 12.3 mM oleic acid in 100 mM Tris-HCl, pH 
8.0, at 22°C for 5 h. Oleate–BSA stock solution was sterilized by passage 
through a 0.2-µm filter and stored at 20°C in small aliquots. To induce 
lipid droplet formation, cells were incubated with 400 µM oleate in DME 
containing 10% bovine calf serum for 18 h. For experiments where lipid 
droplet turnover was studied, cells were then washed three times in fresh 
growth medium and then grown for a further 12–36 h. The cells were then 
fixed with PLP and processed using the standard immunofluorescence pro-
tocol described already. Lipid droplets were detected with 1 µg/ml BODIPY 
493/503 (4,4-difluoro-1,3,5,7,8-pentamethyl-4-bora-3a,4a-diaza-s-indacene; 
Molecular Probes) added to the secondary antibody-staining step.
Online supplemental material
Fig. S1 shows the biochemical analysis of Rab3GAP1 specificity and con-
firms depletion of the Rab18 and Rab3GAP complex using specific anti-
bodies. Fig. S2 shows the effects of Rab18 and Rab3GAP depletion and 
additional ER and Golgi markers. Fig. S3 compares the localization of 
Rab18 and Rab10 to the ER in HeLa and COS7 cells. Figs. S4 and S5 
show lipid storage dynamics in cells depleted of Rab18, Rab3GAP com-
plex, or TBC1D20. Videos 1–5 show ER and Rab18 dynamics in control 
and Rab3GAP- and Rab18-depleted cells. Videos 6–8 show the rescue of 
ER tubular network dynamics by re-expressing mCherry-Rab18 in cells de-
pleted of endogenous Rab18. Video 9 shows a comparison of lipid droplet 
and Rab18 dynamics on the ER. Table S1 contains details of the sequences 
used for RNA interference. Online supplemental material is available at 
http://www.jcb.org/cgi/content/full/jcb.201403026/DC1.
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(Menzel-Gläser; Thermo Fisher Scientific) at a density of 30,000 cells per 
well on a 12-well plate, and then left for 30 h to adhere. The cells 
were transfected with 0.25 µg of mitochondrial-targeted Tom70-3xFLAG-
Rab3GAP2, Myc-Rab3GAP1, and GFP-tagged Rab GTPases in combina-
tion using 1.5 µl Mirus LT1 in 50 µl OptiMEM. After 20 h the cells were 
processed for microscopy.
Membrane fractionations
For membrane fractionation the cells were washed from the dish in PBS 
containing 1 mM EDTA, then homogenized using 20 passes through an 
18-gauge needle in 50 mM Hepes-NaOH, pH 7.4, and 200 mM sucrose. 
Unbroken cells were removed by centrifugation at 1,000 g for 10 min in a 
microfuge. A membrane pellet and cytosol were prepared from this post-
nuclear supernatant by centrifugation at 100,000 g for 60 min in a rotor 
(model TLA-100; Beckman Coulter). Equivalent proportions of the mem-
brane pellet and cytosol were analyzed by Western blotting.
Fixed-cell and live-cell microscopy
For fixed-cell imaging, cells were grown on no. 1.5 glass coverslips, 
washed twice with 2 ml of PBS, and fixed for 2 h in 2 ml PLP (2% [wt/vol] 
paraformaldehyde in 87.5 mM lysine, 87.5 mM sodium phosphate, 
pH 7.4, and 10 mM sodium periodate). Coverslips were washed three 
times in 2 ml (100 mM) sodium phosphate, pH 7.4, before permeabiliza-
tion in 1 mg/ml BSA, 0.12 mg/ml saponin, and 100 mM sodium phosphate, 
pH 7.4, for 30 min. In all cases primary and secondary antibody staining 
was performed in PBS for 60 min at room temperature. Affinity-purified anti-
bodies were used at 1 µg/ml; commercial antibodies were used as directed 
by the manufacturers. DAPI was added to the secondary antibody staining 
solution at 0.3 µg/ml. Coverslips were mounted in Mowiol 4-88 mounting 
medium (EMD Millipore). Fixed samples on glass slides were imaged using 
a 60×/1.35 NA oil immersion objective on an upright microscope (model 
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